INT264065

From wiki-pain
Jump to: navigation, search
Context Info
Confidence 0.01
First Reported 2007
Last Reported 2007
Negated 0
Speculated 0
Reported most in Body
Documents 1
Total Number 1
Disease Relevance 0.63
Pain Relevance 0.14

This is a graph with borders and nodes. Maybe there is an Imagemap used so the nodes may be linking to some Pages.

cytoplasm (Lrtomt)
Lrtomt (Rattus norvegicus)
Pain Link Frequency Relevance Heat
agonist 26 98.80 Very High Very High Very High
depression 5 8.60 Low Low
Pain 4 7.08 Low Low
deep brain stimulation 5 5.00 Very Low Very Low Very Low
Bioavailability 3 5.00 Very Low Very Low Very Low
anesthesia 2 5.00 Very Low Very Low Very Low
fibrosis 2 5.00 Very Low Very Low Very Low
tolerance 2 5.00 Very Low Very Low Very Low
Dopamine 2 5.00 Very Low Very Low Very Low
ergotamine 2 5.00 Very Low Very Low Very Low
Disease Link Frequency Relevance Heat
Toxicity 4 82.32 Quite High
Phobia 2 77.04 Quite High
Disease 49 73.04 Quite High
Dyskinesias 32 48.04 Quite Low
Parkinson's Disease 11 24.72 Low Low
Hallucination 10 17.52 Low Low
Cognitive Disorder 6 14.52 Low Low
Depression 7 8.60 Low Low
Anxiety Disorder 4 8.00 Low Low
Pain 4 7.08 Low Low

Sentences Mentioned In

Key: Protein Mutation Event Anatomy Negation Speculation Pain term Disease term
It has been demonstrated that different strategies for smoothing out the levodopa stimulation pattern by the early use of agonists, as mentioned above as well as with inhibitors of levodopa degradation (catechol-O-methyl transferase or COMT inhibitors), all delay the development of these complications (Olanow et al 2001; Stocchi and Olanow 2004).
Protein_catabolism (degradation) of catechol-O-methyl transferase associated with agonist
1) Confidence 0.01 Published 2007 Journal Neuropsychiatric Disease and Treatment Section Body Doc Link PMC2654791 Disease Relevance 0.63 Pain Relevance 0.14

General Comments

This test has worked.

Personal tools
Namespaces

Variants
Actions
Navigation
Toolbox